ID   WNK4_HUMAN              Reviewed;        1243 AA.
AC   Q96J92; Q8N8X3; Q8N8Z2; Q96DT8; Q9BYS5;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   02-NOV-2010, entry version 91.
DE   RecName: Full=Serine/threonine-protein kinase WNK4;
DE            EC=2.7.11.1;
DE   AltName: Full=Protein kinase lysine-deficient 4;
DE   AltName: Full=Protein kinase with no lysine 4;
GN   Name=WNK4; Synonyms=PRKWNK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), DISEASE, AND VARIANTS PHAII
RP   LYS-562; ALA-564; GLU-565 AND CYS-1185.
RC   TISSUE=Kidney;
RX   MEDLINE=21390047; PubMed=11498583; DOI=10.1126/science.1062844;
RA   Wilson F.H., Disse-Nicodeme S., Choate K.A., Ishikawa K.,
RA   Nelson-Williams C., Desitter I., Gunel M., Milford D.V., Lipkin G.W.,
RA   Achard J.-M., Feely M.P., Dussol B., Berland Y., Unwin R.J., Mayan H.,
RA   Simon D.B., Farfel Z., Jeunemaitre X., Lifton R.P.;
RT   "Human hypertension caused by mutations in WNK kinases.";
RL   Science 293:1107-1112(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RA   Chistiakov D.A.;
RL   Thesis (2001), College de France / Paris, France.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 504-1165 (ISOFORM 3).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 207-418 (ISOFORMS 1/3), TISSUE
RP   SPECIFICITY, AND CHROMOSOMAL LOCATION.
RC   TISSUE=Colon;
RX   MEDLINE=21455683; PubMed=11571656; DOI=10.1038/sj.onc.1204726;
RA   Verissimo F., Jordan P.;
RT   "WNK kinases, a novel protein kinase subfamily in multi-cellular
RT   organisms.";
RL   Oncogene 20:5562-5569(2001).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASP-434; LEU-813; SER-992 AND
RP   PRO-1013.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Regulates the activity of the thiazide-sensitive Na-Cl
CC       cotransporter, SLC12A3, by phosphorylation which appears to
CC       prevent membrane trafficking of SLC12A3. Also inhibits the renal
CC       K(+) channel, KCNJ1, via a kinase-independent mechanism by which
CC       it induces clearance of the protein from the cell surface by
CC       clathrin-dependent endocytosis. WNK4 appears to act as a molecular
CC       switch that can vary the balance between NaCl reabsorption and
CC       K(+) secretion to maintain integrated homeostasis (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium (By similarity).
CC   -!- ENZYME REGULATION: Activation requires autophosphorylation of Ser-
CC       335. Phosphorylation of Ser-331 also promotes increased activity
CC       (By similarity).
CC   -!- SUBUNIT: Interacts with the C-terminal region of KCNJ1 (By
CC       similarity).
CC   -!- SUBCELLULAR LOCATION: Cell junction, tight junction (By
CC       similarity). Note=Present exclusively in intercellular junctions
CC       in the distal convoluted tubule and in both the cytoplasm and
CC       intercellular junctions in the cortical collecting duct. WNK4 is
CC       part of the tight junction complex (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q96J92-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96J92-2; Sequence=VSP_050648, VSP_050649, VSP_050650,
CC                                  VSP_050651;
CC         Note=No experimental confirmation available;
CC       Name=3;
CC         IsoId=Q96J92-3; Sequence=VSP_050652, VSP_050653;
CC         Note=No experimental confirmation available. Incomplete
CC         sequence;
CC   -!- TISSUE SPECIFICITY: Expressed in kidney, colon and skin.
CC   -!- DISEASE: Defects in WNK4 are a cause of pseudohypoaldosteronism
CC       type II (PHAII) [MIM:145260]. PHAII is an autosomal dominant
CC       disease characterized by severe hypertension, hyperkalemia, and
CC       sensitivity to thiazide diuretics which may result from a chloride
CC       shunt in the renal distal nephron.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. WNK subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- CAUTION: Cys-203 is present instead of the conserved Lys which is
CC       expected to be an active site residue. Lys-186 appears to fulfill
CC       the required catalytic function.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC04669.1; Type=Erroneous initiation;
CC       Sequence=CAC48387.1; Type=Frameshift; Positions=4;
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/WNK4";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF390018; AAK91995.1; -; mRNA.
DR   EMBL; AJ316534; CAC48387.1; ALT_FRAME; mRNA.
DR   EMBL; AK096003; BAC04669.1; ALT_INIT; mRNA.
DR   EMBL; AK096052; BAC04688.1; -; mRNA.
DR   EMBL; AJ309861; CAC32991.1; -; mRNA.
DR   IPI; IPI00151141; -.
DR   IPI; IPI00398442; -.
DR   IPI; IPI00398443; -.
DR   RefSeq; NP_115763.2; -.
DR   UniGene; Hs.105448; -.
DR   PDB; 2V3S; X-ray; 1.70 A; C/D=1015-1020.
DR   PDBsum; 2V3S; -.
DR   ProteinModelPortal; Q96J92; -.
DR   SMR; Q96J92; 164-433.
DR   MINT; MINT-5207492; -.
DR   STRING; Q96J92; -.
DR   PhosphoSite; Q96J92; -.
DR   PRIDE; Q96J92; -.
DR   Ensembl; ENST00000246914; ENSP00000246914; ENSG00000126562.
DR   GeneID; 65266; -.
DR   KEGG; hsa:65266; -.
DR   UCSC; uc002ibj.1; human.
DR   UCSC; uc002ibk.1; human.
DR   CTD; 65266; -.
DR   GeneCards; GC17P040932; -.
DR   H-InvDB; HIX0013854; -.
DR   HGNC; HGNC:14544; WNK4.
DR   MIM; 145260; phenotype.
DR   MIM; 601844; gene.
DR   Orphanet; 757; Pseudohypoaldosteronism type 2.
DR   PharmGKB; PA134875400; -.
DR   eggNOG; prNOG09837; -.
DR   HOGENOM; HBG443935; -.
DR   HOVERGEN; HBG050347; -.
DR   InParanoid; Q96J92; -.
DR   OMA; PCHPSPS; -.
DR   OrthoDB; EOG966Z5S; -.
DR   PhylomeDB; Q96J92; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 67398; -.
DR   ArrayExpress; Q96J92; -.
DR   Bgee; Q96J92; -.
DR   CleanEx; HS_WNK4; -.
DR   Genevestigator; Q96J92; -.
DR   GermOnline; ENSG00000126562; Homo sapiens.
DR   GO; GO:0005923; C:tight junction; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; ISS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell junction;
KW   Complete proteome; Disease mutation; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Tight junction; Transferase.
FT   CHAIN         1   1243       Serine/threonine-protein kinase WNK4.
FT                                /FTId=PRO_0000086824.
FT   DOMAIN      174    432       Protein kinase.
FT   NP_BIND     180    188       ATP (By similarity).
FT   ACT_SITE    302    302       Proton acceptor (By similarity).
FT   BINDING     186    186       ATP (By similarity).
FT   MOD_RES     331    331       Phosphoserine; by autocatalysis.
FT   MOD_RES     335    335       Phosphoserine; by autocatalysis.
FT   VAR_SEQ       1    228       Missing (in isoform 2).
FT                                /FTId=VSP_050648.
FT   VAR_SEQ     229    264       QHPNIVRFYDSWKSVLRGQVCIVLVTELMTSGTLKT -> M
FT                                RRRQQGAAGGNFPVGGSFPEDVSPHQDSGYAPSPR (in
FT                                isoform 2).
FT                                /FTId=VSP_050649.
FT   VAR_SEQ     828   1210       Missing (in isoform 2).
FT                                /FTId=VSP_050650.
FT   VAR_SEQ    1145   1165       HLSEVETLQTLQKKEIEDLYS -> PFHALRASSGTCQRWK
FT                                HYRHY (in isoform 3).
FT                                /FTId=VSP_050652.
FT   VAR_SEQ    1166   1243       Missing (in isoform 3).
FT                                /FTId=VSP_050653.
FT   VAR_SEQ    1233   1243       GVTFAGDVGRM -> EAGQRPGKLWLRATVQLRVWGLELRR
FT                                KEMMGRNPKLGAAPNP (in isoform 2).
FT                                /FTId=VSP_050651.
FT   VARIANT     434    434       E -> D (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041330.
FT   VARIANT     562    562       E -> K (in PHAII).
FT                                /FTId=VAR_017588.
FT   VARIANT     564    564       D -> A (in PHAII).
FT                                /FTId=VAR_017589.
FT   VARIANT     565    565       Q -> E (in PHAII).
FT                                /FTId=VAR_017590.
FT   VARIANT     601    601       A -> S (in dbSNP:rs55781437).
FT                                /FTId=VAR_061748.
FT   VARIANT     677    677       R -> W (in dbSNP:rs9896991).
FT                                /FTId=VAR_051685.
FT   VARIANT     813    813       P -> L.
FT                                /FTId=VAR_041331.
FT   VARIANT     961    961       P -> S (in dbSNP:rs2290041).
FT                                /FTId=VAR_051686.
FT   VARIANT     992    992       P -> S (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041332.
FT   VARIANT    1013   1013       L -> P.
FT                                /FTId=VAR_041333.
FT   VARIANT    1185   1185       R -> C (in PHAII).
FT                                /FTId=VAR_017591.
FT   CONFLICT    525    525       R -> C (in Ref. 3; BAC04688).
SQ   SEQUENCE   1243 AA;  134739 MW;  BAC35F0098BA3391 CRC64;
     MLASPATETT VLMSQTEADL ALRPPPPLGT AGQPRLGPPP RRARRFSGKA EPRPRSSRLS
     RRSSVDLGLL SSWSLPASPA PDPPDPPDSA GPGPARSPPP SSKEPPEGTW TEGAPVKAAE
     DSARPELPDS AVGPGSREPL RVPEAVALER RREQEEKEDM ETQAVATSPD GRYLKFDIEI
     GRGSFKTVYR GLDTDTTVEV AWCELQTRKL SRAERQRFSE EVEMLKGLQH PNIVRFYDSW
     KSVLRGQVCI VLVTELMTSG TLKTYLRRFR EMKPRVLQRW SRQILRGLHF LHSRVPPILH
     RDLKCDNVFI TGPTGSVKIG DLGLATLKRA SFAKSVIGTP EFMAPEMYEE KYDEAVDVYA
     FGMCMLEMAT SEYPYSECQN AAQIYRKVTS GRKPNSFHKV KIPEVKEIIE GCIRTDKNER
     FTIQDLLAHA FFREERGVHV ELAEEDDGEK PGLKLWLRME DARRGGRPRD NQAIEFLFQL
     GRDAAEEVAQ EMVALGLVCE ADYQPVARAV RERVAAIQRK REKLRKAREL EALPPEPGPP
     PATVPMAPGP PSVFPPEPEE PEADQHQPFL FRHASYSSTT SDCETDGYLS SSGFLDASDP
     ALQPPGGVPS SLAESHLCLP SAFALSIPRS GPGSDFSPGD SYASDAASGL SDVGEGMGQM
     RRPPGRNLRR RPRSRLRVTS VSDQNDRVVE CQLQTHNSKM VTFRFDLDGD SPEEIAAAMV
     YNEFILPSER DGFLRRIREI IQRVETLLKR DTGPMEAAED TLSPQEEPAP LPALPVPLPD
     PSNEELQSST SLEHRSWTAF STSSSSPGTP LSPGNPFSPG TPISPGPIFP ITSPPCHPSP
     SPFSPISSQV SSNPSPHPTS SPLPFSSSTP EFPVPLSQCP WSSLPTTSPP TFSPTCSQVT
     LSSPFFPPCP STSSFPSTTA APLLSLASAF SLAVMTVAQS LLSPSPGLLS QSPPAPPSPL
     PSLPLPPPVA PGGQESPSPH TAEVESEASP PPARPLPGEA RLAPISEEGK PQLVGRFQVT
     SSKEPAEPLP LQPTSPTLSG SPKPSTPQLT SESSDTEDSA GGGPETREAL AESDRAAEGL
     GAGVEEEGDD GKEPQVGGSP QPLSHPSPVW MNYSYSSLCL SSEESESSGE DEEFWAELQS
     LRQKHLSEVE TLQTLQKKEI EDLYSRLGKQ PPPGIVAPAA MLSSRQRRLS KGSFPTSRRN
     SLQRSEPPGP GIMRRNSLSG SSTGSQEQRA SKGVTFAGDV GRM
//
